WHO recommendation on routes of oxytocin administration for the prevention of postpartum haemorrhage after vaginal birth
In 2019, the Executive Guideline Steering Group (GSG) for World Health Organization (WHO) maternal and perinatal health recommendations prioritized the updating of the existing WHO recommendations for intravenous (IV) versus intramuscular (IM) oxytocin for prevention of PPH after vaginal birth in re...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Geneva, Switzerland
World Health Organization
[2020], 2020
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | In 2019, the Executive Guideline Steering Group (GSG) for World Health Organization (WHO) maternal and perinatal health recommendations prioritized the updating of the existing WHO recommendations for intravenous (IV) versus intramuscular (IM) oxytocin for prevention of PPH after vaginal birth in response to the availability of new evidence. The recommendation in this document thus supersedes the previous WHO recommendations for the prevention of PPH as published in the 2012 guideline: WHO recommendations for the prevention and treatment of postpartum haemorrhage |
|---|---|
| Physical Description: | 1 PDF file (ix, 39 pages) illustrations |
| ISBN: | 9789240013933 9789240013926 |